Evidence map›Paper›PMID 37334352›Full record

ReviewFrontiers in immunology2023

Case Report: Localized bullous pemphigoid induced by local triggers: a case series and a proposal for diagnostic criteria based on a literature review.

Lluís Corbella-Bagot, Javier Gil-Lianes, Javier Fernández-Vela, Ignasi Martí-Martí, Marta Alegre-Fernández, Irene Fuertes, Patricia Garbayo-Salmons, Xavier Bosch-Amate, Antonio Guilabert, José M Mascaró

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Lluís Corbella-BagotDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Javier Gil-LianesDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Javier Fernández-VelaDepartment of Dermatology, Hospital General de Granollers, Granollers, Spain.
Ignasi Martí-MartíDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Marta Alegre-FernándezDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Irene FuertesDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Patricia Garbayo-SalmonsDepartment of Dermatology, Hospital Mútua de Terrassa, Terrassa, Spain.
Xavier Bosch-AmateDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Antonio GuilabertDepartment of Dermatology, Hospital General de Granollers, Granollers, Spain.
José M MascaróDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Universitat de Barcelona · ESHospital Clínic de Barcelona · ESHospital General de Granollers · ESUniversity Hospital Mútua de Terrassa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Localized bullous pemphigoid (LBP) is an infrequent bullous pemphigoid (BP) variant restricted to a body region. According to the most compelling evidence, LBP occurs in patients with pre-existent serum antibodies against the basement membrane zone, which occasionally acquire the capacity to induce disease after the influence of different local factors acting as triggers. Methods: We hereby present a multicenter cohort of 7 patients with LBP developed after local triggers: radiotherapy, thermal burns, surgery, rosacea, edema and a paretic leg. In addition, we conducted a review of the literature, and we propose a set of diagnostic criteria for LBP, also based on our case series and the 2022 BP guidelines from the European Academy of Dermatology and Venereology. Results: During follow-up, three of the patients from our series evolved to a generalized BP, with only one requiring hospitalization. Our literature search retrieved 47 articles including a total of 108 patients with LBP, with a 63% with a potential local precipitating factor previous to their diagnosis. LBP mostly affected older females, and a subsequent generalized progression occurred in 16.7% of the cases. The most frequently involved areas were the lower limbs. Radiation therapy and surgery were responsible for the inducement of nearly 2 in 3 cases of LBP. We observed a significantly higher risk of generalization in cases where the trigger led to the developing of LBP earlier (p=0.016). Our statistical analysis did not detect any other prognosis factor for generalization when assessing direct immunofluorescence, histological and serological results, or other patient related factors. Conclusion: LBP should be suspected in patients with recurrent localized bullous eruptions. The presence of a trauma history in the same anatomic area is reported in most cases.

Indexed as

Pemphigoid, BullousSkin Diseases, VesiculobullousAntibodiesFemaleHumansMulticenter Studies as TopicPrecipitating FactorsResearchAntibodiesbullous pemphigoidcase reportcriterialocalized bullous pemphigoidprecipitating factorsradiotherapyrosaceatriggers

Identifiers

PMID37334352
PMCPMC10272756
OpenAlexW4379230110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.